Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05049_nanopub.RA1ymJtrLkMBlH8hyiYmjIMGxrn0e5pmVmvVrp7qPZZiU#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05049 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05049 label "DDP733 [drugbank:DB05049]" assertion.
- drugbank:DB05049 seeAlso DB05049 assertion.
- drugbank:DB05049 description "DDP733 is an oral prokinetic drug which Dynogen is developing as a treatment for both Irritable Bowel Syndrome with constipation (IBS-c) and nocturnal gastroesophageal reflux disease (NGERD). It is a partial agonist of the serotonin type 3 receptor (5-HT3). Serotonin is a neurotransmitter that is known to be involved in the control of the gastrointestinal (GI) system. Preclinical studies of DDP733 established the compoundâs prokinetic properties (the ability to promote the motility of the GI tract)." assertion.
- drugbank:DB05049 identifier "drugbank:DB05049" assertion.
- drugbank:DB05049 title "DDP733" assertion.
- drugbank:DB05049 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05049 drugbank_vocabulary:drugbank-id "DB05049" assertion.
- drugbank:DB05049 bio2rdf_vocabulary:x-identifiers.org DB05049 assertion.
- drugbank:DB05049 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05049" assertion.
- drugbank:DB05049 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05049 bio2rdf_vocabulary:identifier "DB05049" assertion.